About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 100 record(s)
Req # A-2021-05511
Copies of all communications between Douglas Clark and officials in CADTH and pCPA regarding the drug Trikafta.Organization: Patented Medicine Prices Review Board Canada
April 2021
Req # A-2021-05527
Copies of all records relating to bank account "62200" along with capital inflows/outflows from that account. Include all bank entries with the term "VCU" along with the number of people who have access to the account.Organization: Patented Medicine Prices Review Board Canada
April 2021
Req # A-2021-03061
Copies of the emails related to the implementation of yoga sessions for PMPRB staff at the executive level and above from January 1, 2020 to January 1, 2021.Organization: Patented Medicine Prices Review Board Canada
March 2021
Req # A-2021-03062
Copies of the emails related to the implementation of the weekly meditation sessions for the PMPRB staff at the executive level and above from November 1, 2020 to February 17, 2021.Organization: Patented Medicine Prices Review Board Canada
March 2021
Req # A-2021-03660
Provide a breakdown of specific dollar totals levied by the PMPRB against pharmaceutical companies in the form of excessive revenue payments. For each excessive revenue payment, break it down by date, company charged, drug in question, and amount levied.Organization: Patented Medicine Prices Review Board Canada
March 2021
Req # A-2020-00811
Provide the specific dollar penalties and total claimed by the PMPRB from the use of excessive prices penalty since 2005 and documentation showing what the money was used for.Organization: Patented Medicine Prices Review Board Canada
February 2021
Req # A-2020-00813
Copies of documents related to the use of the excessive price penalty against Alexion Pharmaceuticals.Organization: Patented Medicine Prices Review Board Canada
February 2021
Req # A-2021-00815
Copies of all emails to/from cc'ing Guillaume Coullaird regarding the use of the excessive prices penalty and future use against pharmaceutical companies from January 1, 2019 to January 18, 2021.Organization: Patented Medicine Prices Review Board Canada
February 2021
Req # A-2021-01073
Copies of all emails to/from and cc'ing Douglas Clark, Mitchell Levine and Melanie Bourassa-Forcier regarding the decision to delay the implementation of the PMPRB guidelines to Summer 2021 from November 1, 2020 to January 20, 2021.Organization: Patented Medicine Prices Review Board Canada
February 2021
Req # A-2021-01083
Copies of all emails to/from and cc'ing Douglas Clark, Mitchell Levine and Melanie Bourassa-Forcier regarding any directives from the Health minister's office regarding the implementation of the new PMPRB guidelines from January 1, 2020 to January 20, 2021.Organization: Patented Medicine Prices Review Board Canada
February 2021